Versarien (GB:VRS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Versarien PLC has signed a distribution agreement to bring innovative graphene-based biosensors, developed in South Korea, to the UK and European markets. These advanced sensors, featuring a novel graphene barristor technology, promise significant advancements in medical diagnostics by overcoming limitations of traditional graphene transistors. The collaboration is expected to expand with future developments in various sensor technologies.
For further insights into GB:VRS stock, check out TipRanks’ Stock Analysis page.